These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5383011)

  • 1. [Comparative bacteriological development in 2 groups of patients with severe pulmonary tuberculosis, 1 treated with a rifampicin-base combination, the other with an INH-base combination].
    Augier J; Parrot R; Marchal G; Gillet P
    Rev Tuberc Pneumol (Paris); 1969; 33(3):414-23. PubMed ID: 5383011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacteriological evolution established in 406 tuberculosis patients treated with various combinations with or without rifampicin or INH].
    Parrot R; Augier J; Auroy C; Baron A; Boscus M; Deshais B; Gillet P; Laparre C; Marchal G; Naghavi H; Plawner S; Schoepff G
    Rev Tuberc Pneumol (Paris); 1970; 34(5):709-13. PubMed ID: 5496793
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of probable congenital tuberculosis successfully treated with rifampicin and INH.
    Kotchabhakdi N; Junnanond C
    J Med Assoc Thai; 1978 Aug; 61(8):481-8. PubMed ID: 690536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment].
    Oury M; Tuchais E; Viallet S; Chauvet G
    Rev Tuberc Pneumol (Paris); 1971 Dec; 35(8):819-28. PubMed ID: 5151119
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin in combination with isoniazid in the treatment childhood tuberculosis.
    Rahaju NN; Sutoto ; Rahaju N; Budiman I; Sutejo
    Paediatr Indones; 1976; 16(11-12):544-53. PubMed ID: 1088375
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigation on bacteriological relapses in cases of pulmonary tuberculosis treated with INH and RFP--report of the 27th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Mochizuki K; Shigeto E; Kobayashi Y; Nagasawa S
    Kekkaku; 1987 May; 62(5):265-80. PubMed ID: 3626256
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration.
    Farmakis M; Travlou O; Aroni S; Fertakis A
    Arzneimittelforschung; 1992 Aug; 42(8):1041-4. PubMed ID: 1418078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [56 recent pulmonary tuberculosis cases treated with combined rifampicin-isoniazid in a controlled experiment].
    Constans P; Morin Y; Saint-Paul M; Bonnaud G; Coury C; Bariéty M
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):145-62. PubMed ID: 4916251
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative therapeutic activity of rifampicin and isoniazid in different densities of microbial population in the lungs of experimental animals].
    Sodikov ES; Ismatullaev F
    Probl Tuberk; 1986; (6):50-3. PubMed ID: 3092209
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 12. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
    Wada M; Seita A; Mori T; Ogata H; Sugie T; Sugita H
    Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Light and electron microscopy studies of the liver in tuberculosis patients receiving rifampin and isoniazid].
    Pilheu JA; de Salvo MC; Koch O; Barcat JA
    Medicina (B Aires); 1981; 41(4):439-45. PubMed ID: 7339434
    [No Abstract]   [Full Text] [Related]  

  • 18. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the indication of surgical treatment for pulmonary tuberculosis in accordance with the introduction of rifampicin based on bacteriological findings on culture of resected specimens (author's transl)].
    Kekkaku; 1977 Jul; 52(7):353-60. PubMed ID: 409871
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
    Kuz'min AV; Vasil'eva IA; Chernousova LN
    Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.